The domain within your query sequence starts at position 271 and ends at position 357; the E-value for the HOLI domain shown below is 6e-46.
GLLDPGMLVNIQQPLIREDGTVLLAADSKAETSQGALGTLANVVTSLANLSESLNNGDAS EMQPEDQSASEITRAFDTLAKALNTTD
The domain was found using the schnipsel database
HOLILigand binding domain of hormone receptors |
|---|
| SMART accession number: | SM00430 |
|---|---|
| Description: | - |
| Interpro abstract (IPR000536): | Nuclear receptors (NRs), such as the receptors for steroids and thyroid hormones, retinoids and vitamin D3, are one of the most abundant classes of transcriptional regulators in animals (metazoans). They regulate diverse functions, such as homeostasis, reproduction, development and metabolism. The most prominent feature differentiating them from other transcription factors is their capacity to bind small hydrophobic molecules specifically. These ligands constitute regulatory signals, which modify the NR transcriptional activity through conformational changes. Prototypical NRs share a common structural organisation with a variable N-terminal domain that contains a constitutively active activation function (AF)-1, a conserved DNA- binding domain (DBD) consisting of two zinc fingers, a linker region, and a C-terminal ligand-binding domain (LBD), also called HOLI domain [ (PUBMED:12538758) (PUBMED:15105832) (PUBMED:24844133) ]. The NR LBD plays a crucial role in ligand-mediated NR activity. In addition to its role is ligand recognition, the LBD also contains a ligand-dependent AF-2. Conformational changes in AF-2 induced by various ligands can modulate interactions with conserved motifs of coregulatory proteins. Specifically, the binding of ligands to the LBD determines the recruiting of transcriptional coregulators which triggers induction or repression of target genes. The coregulators include coactivators like the p160 factors also referred to as the steroid receptor coactivators (SRC) family, and corepressors such as SMART (silencing mediator for retinoid and thyroid hormone receptors) and N-CoR (nuclear corepressor) [ (PUBMED:24361687) (PUBMED:11050318) (PUBMED:9640540) (PUBMED:20723571) ]. The overall structure of NR LBD is composed of about 11-13 alpha-helices that are arranged into a three-layer antiparallel alpha-helical sandwich with the three long helices (helices 3, 7, and 10) forming the two outer layers. The middle layer of helices (helices 4, 5, 8 and 9) is present only in the top half of the domain but is missing from the bottom half, thereby creating a cavity, so called ligand-binding pocket, for ligand binding in most receptors. The bound ligands stabilize the NR conformation through direct contacts with multiple structural elements including helices H3, H5, H6, H7, H10, and the loop proceeding the AF-2 helix. The C-terminal activation region also forms an alpha-helix (AF-2), which can adopt multiple conformation depending on the nature of the bound ligand. Helices 3,4 and 12 enclose a shallow hydrophobic groove which is the site for coregulator binding. Despite the conserved fold of NR LBDs, the ligand-binding pocket is the least conserved region among different NR LBDs [ (PUBMED:11050318) (PUBMED:9640540) (PUBMED:20723571) ]. |
| Family alignment: |
There are 28310 HOLI domains in 28124 proteins in SMART's nrdb database.
Click on the following links for more information.
- Evolution (species in which this domain is found)
-
Taxonomic distribution of proteins containing HOLI domain.
This tree includes only several representative species. The complete taxonomic breakdown of all proteins with HOLI domain is also avaliable.
Click on the protein counts, or double click on taxonomic names to display all proteins containing HOLI domain in the selected taxonomic class.
- Cellular role (predicted cellular role)
-
Binding / catalysis: hormones
- Literature (relevant references for this domain)
-
Primary literature is listed below; Automatically-derived, secondary literature is also avaliable.
- Gronemeyer H, Laudet V
- Transcription factors 3: nuclear receptors.
- Protein Profile. 1995; 2: 1173-308
- Evans RM
- The steroid and thyroid hormone receptor superfamily.
- Science. 1988; 240: 889-95
- Display abstract
Analyses of steroid receptors are important for understanding molecular details of transcriptional control, as well as providing insight as to how an individual transacting factor contributes to cell identity and function. These studies have led to the identification of a superfamily of regulatory proteins that include receptors for thyroid hormone and the vertebrate morphogen retinoic acid. Although animals employ complex and often distinct ways to control their physiology and development, the discovery of receptor-related molecules in a wide range of species suggests that mechanisms underlying morphogenesis and homeostasis may be more ubiquitous than previously expected.
- Disease (disease genes where sequence variants are found in this domain)
-
SwissProt sequences and OMIM curated human diseases associated with missense mutations within the HOLI domain.
Protein Disease Androgen receptor (P10275) (SMART) OMIM:313700: Androgen insensitivity, several forms ; Spinal and bulbar muscular atrophy of Kennedy
OMIM:313200: Prostate cancer ; Perineal hypospadias ; Breast cancer, male, with Reifenstein syndromeEstrogen receptor (P03372) (SMART) OMIM:133430: Breast cancer ; Estrogen resistance UNKNOWN (SMART) OMIM:300200: Adrenal hypoplasia, congenital, with hypogonadotropic hypogonadism ; Dosage-sensitive sex reversal
OMIM:300018:Hepatocyte nuclear factor 4-alpha (P41235) (SMART) OMIM:600281: MODY, type 1
OMIM:125850: {Diabetes mellitus, noninsulin-dependent}
OMIM:125853:Vitamin D3 receptor (P11473) (SMART) OMIM:601769: Rickets, vitamin D-resistant
OMIM:277440: ?Osteoporosis, involutionalPhotoreceptor-specific nuclear receptor (Q9Y5X4) (SMART) OMIM:604485: Enhanced S-cone syndrome
OMIM:268100: Retinitis pigmentosa, late onset
OMIM:268000:Glucocorticoid receptor (P04150) (SMART) OMIM:138040: Cortisol resistance Peroxisome proliferator-activated receptor gamma (P37231) (SMART) OMIM:601487: Obesity, severe
OMIM:601665: [Obesity, protection against] ; Diabetes mellitus, insulin-resistant, with acanthosis nigricans and hypertension
OMIM:604367:UNKNOWN (SMART) OMIM:190160: Thyroid hormone resistance
OMIM:274300:
OMIM:188570: - Metabolism (metabolic pathways involving proteins which contain this domain)
-
% proteins involved KEGG pathway ID Description 20.21 map03320 PPAR signaling pathway 11.70 map04920 Adipocytokine signaling pathway 11.35 map05216 Thyroid cancer 10.99 map05222 Small cell lung cancer 10.99 map05223 Non-small cell lung cancer 8.87 map04950 Maturity onset diabetes of the young 8.16 map04080 Neuroactive ligand-receptor interaction 4.96 map05221 Acute myeloid leukemia 3.19 map04310 Wnt signaling pathway 2.84 map04010 MAPK signaling pathway 2.84 map05215 Prostate cancer 2.48 map04914 Progesterone-mediated oocyte maturation 1.42 map04710 Circadian rhythm This information is based on mapping of SMART genomic protein database to KEGG orthologous groups. Percentage points are related to the number of proteins with HOLI domain which could be assigned to a KEGG orthologous group, and not all proteins containing HOLI domain. Please note that proteins can be included in multiple pathways, ie. the numbers above will not always add up to 100%.
- Structure (3D structures containing this domain)
3D Structures of HOLI domains in PDB
PDB code Main view Title 1a28 
HORMONE-BOUND HUMAN PROGESTERONE RECEPTOR LIGAND-BINDING DOMAIN 1a52 
ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN COMPLEXED TO ESTRADIOL 1bsx 
STRUCTURE AND SPECIFICITY OF NUCLEAR RECEPTOR-COACTIVATOR INTERACTIONS 1db1 
CRYSTAL STRUCTURE OF THE NUCLEAR RECEPTOR FOR VITAMIN D COMPLEXED TO VITAMIN D 1dkf 
CRYSTAL STRUCTURE OF A HETERODIMERIC COMPLEX OF RAR AND RXR LIGAND-BINDING DOMAINS 1e3g 
human Androgen Receptor Ligand Binding in complex with the ligand metribolone (R1881) 1e3k 
human Progesteron Receptor Ligand Binding Domain in complex with the ligand metribolone (R1881) 1ere 
HUMAN ESTROGEN RECEPTOR LIGAND-BINDING DOMAIN IN COMPLEX WITH 17BETA-ESTRADIOL 1err 
HUMAN ESTROGEN RECEPTOR LIGAND-BINDING DOMAIN IN COMPLEX WITH RALOXIFENE 1exa 
ENANTIOMER DISCRIMINATION ILLUSTRATED BY CRYSTAL STRUCTURES OF THE HUMAN RETINOIC ACID RECEPTOR HRARGAMMA LIGAND BINDING DOMAIN: THE COMPLEX WITH THE ACTIVE R-ENANTIOMER BMS270394. 1exx 
ENANTIOMER DISCRIMINATION ILLUSTRATED BY CRYSTAL STRUCTURES OF THE HUMAN RETINOIC ACID RECEPTOR HRARGAMMA LIGAND BINDING DOMAIN: THE COMPLEX WITH THE INACTIVE S-ENANTIOMER BMS270395. 1fby 
CRYSTAL STRUCTURE OF THE HUMAN RXR ALPHA LIGAND BINDING DOMAIN BOUND TO 9-CIS RETINOIC ACID 1fcx 
ISOTYPE SELECTIVITY OF THE HUMAN RETINOIC ACID NUCLEAR RECEPTOR HRAR: THE COMPLEX WITH THE RARGAMMA-SELECTIVE RETINOID BMS184394 1fcy 
ISOTYPE SELECTIVITY OF THE HUMAN RETINOIC ACID NUCLEAR RECEPTOR HRAR: THE COMPLEX WITH THE RARBETA/GAMMA-SELECTIVE RETINOID CD564 1fcz 
ISOTYPE SELECTIVITY OF THE HUMAN RETINOIC ACID NUCLEAR RECEPTOR HRAR: THE COMPLEX WITH THE PANAGONIST RETINOID BMS181156 1fd0 
ISOTYPE SELECTIVITY OF THE HUMAN RETINOIC ACID NUCLEAR RECEPTOR HRAR: THE COMPLEX WITH THE RARGAMMA-SELECTIVE RETINOID SR11254 1fm6 
THE 2.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HETERODIMER OF THE HUMAN RXRALPHA AND PPARGAMMA LIGAND BINDING DOMAINS RESPECTIVELY BOUND WITH 9-CIS RETINOIC ACID AND ROSIGLITAZONE AND CO-ACTIVATOR PEPTIDES. 1fm9 
THE 2.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HETERODIMER OF THE HUMAN RXRALPHA AND PPARGAMMA LIGAND BINDING DOMAINS RESPECTIVELY BOUND WITH 9-CIS RETINOIC ACID AND GI262570 AND CO-ACTIVATOR PEPTIDES. 1g1u 
THE 2.5 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE RXRALPHA LIGAND BINDING DOMAIN IN TETRAMER IN THE ABSENCE OF LIGAND 1g2n 
CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF THE ULTRASPIRACLE PROTEIN USP, THE ORTHOLOG OF RXRS IN INSECTS 1g50 
CRYSTAL STRUCTURE OF A WILD TYPE HER ALPHA LBD AT 2.9 ANGSTROM RESOLUTION 1g5y 
THE 2.0 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE RXRALPHA LIGAND BINDING DOMAIN TETRAMER IN THE PRESENCE OF A NON-ACTIVATING RETINOIC ACID ISOMER. 1gs4 
Structural basis for the glucocorticoid response in a mutant human androgen receptor (ARccr) derived from an androgen-independent prostate cancer 1gwq 
HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH RALOXIFENE CORE AND TIF2 NRBOX2 PEPTIDE 1gwr 
HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH 17BETA-OESTRADIOL AND TIF2 NRBOX3 PEPTIDE 1gwx 
MOLECULAR RECOGNITION OF FATTY ACIDS BY PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS 1h9u 
The structure of the human retinoid-X-receptor beta ligand binding domain in complex with the specific synthetic agonist LG100268 1hg4 
Ultraspiracle ligand binding domain from Drosophila melanogaster 1hj1 
RAT OESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN IN COMPLEX WITH PURE ANTIOESTROGEN ICI164,384 1i37 
CRYSTAL STRUCTURE OF THE RAT ANDROGEN RECEPTOR LIGAND BINDING DOMAIN COMPLEX WITH DIHYDROTESTOSTERONE 1i38 
CRYSTAL STRUCTURE OF THE RAT ANDROGEN RECEPTOR LIGAND BINDING DOMAIN T877A MUTANT COMPLEX WITH DIHYDROTESTOSTERONE 1i7g 
CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN FROM HUMAN PPAR-ALPHA IN COMPLEX WITH THE AGONIST AZ 242 1i7i 
CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF HUMAN PPAR-GAMMA IN COMPLEX WITH THE AGONIST AZ 242 1ie8 
Crystal Structure Of The Nuclear Receptor For Vitamin D Ligand Binding Domain Bound to KH1060 1ie9 
Crystal Structure Of The Nuclear Receptor For Vitamin D Ligand Binding Domain Bound to MC1288 1ilg 
Crystal Structure of Apo Human Pregnane X Receptor Ligand Binding Domain 1ilh 
Crystal Structure of Human Pregnane X Receptor Ligand Binding Domain Bound to SR12813 1k4w 
X-ray structure of the orphan nuclear receptor ROR beta ligand-binding domain in the active conformation 1k74 
The 2.3 Angstrom resolution crystal structure of the heterodimer of the human PPARgamma and RXRalpha ligand binding domains respectively bound with GW409544 and 9-cis retinoic acid and co-activator peptides. 1k7l 
The 2.5 Angstrom resolution crystal structure of the human PPARalpha ligand binding domain bound with GW409544 and a co-activator peptide. 1kkq 
Crystal structure of the human PPAR-alpha ligand-binding domain in complex with an antagonist GW6471 and a SMRT corepressor motif 1knu 
LIGAND BINDING DOMAIN OF THE HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA IN COMPLEX WITH A SYNTHETIC AGONIST 1kv6 
X-ray structure of the orphan nuclear receptor ERR3 ligand-binding domain in the constitutively active conformation 1l2i 
Human Estrogen Receptor alpha Ligand-binding Domain in Complex with (R,R)-5,11-cis-diethyl-5,6,11,12-tetrahydrochrysene-2,8-diol and a Glucocorticoid Receptor Interacting Protein 1 NR box II Peptide 1l2j 
Human Estrogen Receptor beta Ligand-binding Domain in Complex with (R,R)-5,11-cis-diethyl-5,6,11,12-tetrahydrochrysene-2,8-diol 1lbd 
LIGAND-BINDING DOMAIN OF THE HUMAN NUCLEAR RECEPTOR RXR-ALPHA 1lv2 
Hepatocyte Nuclear Factor 4 is a Transcription Factor that Constitutively Binds Fatty Acids 1m13 
Crystal Structure of the Human Pregane X Receptor Ligand Binding Domain in Complex with Hyperforin, a Constituent of St. John's Wort 1m2z 
Crystal structure of a dimer complex of the human glucocorticoid receptor ligand-binding domain bound to dexamethasone and a TIF2 coactivator motif 1m7w 
HNF4a ligand binding domain with bound fatty acid 1mv9 
Crystal Structure of the human RXR alpha ligand binding domain bound to the eicosanoid DHA (Docosa Hexaenoic Acid) and a coactivator peptide 1mvc 
Crystal structure of the human RXR alpha ligand binding domain bound to the synthetic agonist compound BMS 649 and a coactivator peptide 1mzn 
CRYSTAL STRUCTURE at 1.9 ANGSTROEMS RESOLUTION OF THE HOMODIMER OF HUMAN RXR ALPHA LIGAND BINDING DOMAIN BOUND TO THE SYNTHETIC AGONIST COMPOUND BMS 649 AND A COACTIVATOR PEPTIDE 1n46 
CRYSTAL STRUCTURE OF HUMAN TR BETA LIGAND-BINDING DOMAIN COMPLEXED WITH A POTENT SUBTYPE-SELECTIVE THYROMIMETIC 1n4h 
Characterization of ligands for the orphan nuclear receptor RORbeta 1n83 
Crystal Structure of the complex between the Orphan Nuclear Hormone Receptor ROR(alpha)-LBD and Cholesterol 1nav 
Thyroid Receptor Alpha in complex with an agonist selective for Thyroid Receptor Beta1 1nax 
Thyroid receptor beta1 in complex with a beta-selective ligand 1nde 
Estrogen Receptor beta with Selective Triazine Modulator 1nhz 
Crystal Structure of the Antagonist Form of Glucocorticoid Receptor 1nq0 
TR Receptor Mutations Conferring Hormone Resistance and Reduced Corepressor Release Exhibit Decreased Stability in the Nterminal LBD 1nq1 
TR Receptor Mutations Conferring Hormone Resistance and Reduced Corepressor Release Exhibit Decreased Stability in the Nterminal LBD 1nq2 
Two RTH Mutants with Impaired Hormone Binding 1nq7 
Characterization of ligands for the orphan nuclear receptor RORbeta 1nrl 
Crystal Structure of the human PXR-LBD in complex with an SRC-1 coactivator peptide and SR12813 1nuo 
Two RTH Mutants with Impaired Hormone Binding 1nyx 
Ligand binding domain of the human peroxisome proliferator activated receptor gamma in complex with an agonist 1osh 
A Chemical, Genetic, and Structural Analysis of the nuclear bile acid receptor FXR 1osv 
STRUCTURAL BASIS FOR BILE ACID BINDING AND ACTIVATION OF THE NUCLEAR RECEPTOR FXR 1ot7 
Structural Basis for 3-deoxy-CDCA Binding and Activation of FXR 1ovl 
Crystal Structure of Nurr1 LBD 1p8d 
X-Ray Crystal Structure of LXR Ligand Binding Domain with 24(S),25-epoxycholesterol 1p93 
CRYSTAL STRUCTURE OF THE AGONIST FORM OF GLUCOCORTICOID RECEPTOR 1pcg 
Helix-stabilized cyclic peptides as selective inhibitors of steroid receptor-coactivator interactions 1pdu 
Ligand-binding domain of Drosophila orphan nuclear receptor DHR38 1pk5 
Crystal structure of the orphan nuclear receptor LRH-1 1pq6 
HUMAN LXR BETA HORMONE RECEPTOR / GW3965 COMPLEX 1pq9 
HUMAN LXR BETA HORMONE RECEPTOR COMPLEXED WITH T0901317 COMPLEX 1pqc 
HUMAN LXR BETA HORMONE RECEPTOR COMPLEXED WITH T0901317 1prg 
LIGAND BINDING DOMAIN OF THE HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 1pzl 
Crystal structure of HNF4a LBD in complex with the ligand and the coactivator SRC-1 peptide 1q4x 
Crystal Structure of Human Thyroid Hormone Receptor beta LBD in complex with specific agonist GC-24 1qkm 
HUMAN OESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN IN COMPLEX WITH PARTIAL AGONIST GENISTEIN 1qkn 
RAT OESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN IN COMPLEX WITH ANTAGONIST RALOXIFENE 1qkt 
MUTANT ESTROGEN NUCLEAR RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH ESTRADIOL 1qku 
WILD TYPE ESTROGEN NUCLEAR RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH ESTRADIOL 1r1k 
Crystal structure of the ligand-binding domains of the heterodimer EcR/USP bound to ponasterone A 1r20 
Crystal structure of the ligand-binding domains of the heterodimer EcR/USP bound to the synthetic agonist BYI06830 1r5k 
Human Estrogen Receptor alpha Ligand-Binding Domain In Complex With GW5638 1r6g 
Crystal structure of the thyroid hormone receptor beta ligand binding domain in complex with a beta selective compound 1rdt 
Crystal Structure of a new rexinoid bound to the RXRalpha ligand binding doamin in the RXRalpha/PPARgamma heterodimer 1rjk 
crystal structure of the rat vitamin D receptor ligand binding domain complexed with 2MD and a synthetic peptide containing the NR2 box of DRIP 205 1rk3 
crystal structure of the rat vitamin D receptor ligand binding domain complexed with 1,25-dihydroxyvitamin D3 and a synthetic peptide containing the NR2 box of DRIP 205 1rkg 
crystal structure of the rat vitamin D receptor ligand binding domain complexed with 2MbisP and a synthetic peptide containing the NR2 box of DRIP 205 1rkh 
crystal structure of the rat vitamin D receptor ligand binding domain complexed with 2AM20R and a synthetic peptide containing the NR2 box of DRIP 205 1s0x 
Crystal structure of the human RORalpha ligand binding domain in complex with cholesterol sulfate at 2.2A 1s0z 
Crystal structure of the VDR LBD complexed to seocalcitol. 1s19 
Crystal structure of VDR ligand binding domain complexed to calcipotriol. 1s9p 
crystal structure of the ligand-binding domain of the estrogen-related receptor gamma in complex with diethylstilbestrol 1s9q 
crystal structure of the ligand-binding domain of the estrogen-related receptor gamma in complex with 4-hydroxytamoxifen 1sj0 
Human Estrogen Receptor Alpha Ligand-binding Domain in Complex with the Antagonist Ligand 4-D 1skx 
Structural Disorder in the Complex of Human PXR and the Macrolide Antibiotic Rifampicin 1sqn 
Progesterone Receptor Ligand Binding Domain with bound Norethindrone 1sr7 
Progesterone Receptor Hormone Binding Domain with Bound Mometasone Furoate 1t5z 
Crystal Structure of the Androgen Receptor Ligand Binding Domain (LBD) with DHT and a peptide derived from its physiological coactivator ARA70 1t63 
Crystal Structure of the Androgen Receptor Ligand Binding Domain with DHT and a peptide derived from its physiological coactivator GRIP1 NR box3 1t65 
Crystal structure of the androgen receptor ligand binding domain with DHT and a peptide derived form its physiological coactivator GRIP1 NR box 2 bound in a non-helical conformation 1t73 
Crystal structure of the androgen receptor ligand binding domain in complex with a FxxFF motif 1t74 
Crystal structure of the androgen receptor ligand binding domain in complex with a WxxLF motif 1t76 
Crystal structure of the androgen receptor ligand binding domain in complex with a WxxVW motif 1t79 
Crystal structure of the androgen receptor ligand binding domain in complex with a FxxLW motif 1t7f 
Crystal structure of the androgen receptor ligand binding domain in complex with a LxxLL motif 1t7m 
Crystal structure of the androgen receptor ligand binding domain in complex with a FxxYF motif 1t7r 
Crystal structure of the androgen receptor ligand binding domain in complex with a FxxLF motif 1t7t 
Crystal structure of the androgen receptor ligand binding domain in complex with 5-alpha dihydrotestosterone 1tfc 
CRYSTAL STRUCTURE OF THE LIGAND-BINDING DOMAIN OF THE ESTROGEN-RELATED RECEPTOR GAMMA IN COMPLEX WITH A STEROID RECEPTOR COACTIVATOR-1 PEPTIDE 1txi 
Crystal structure of the vdr ligand binding domain complexed to TX522 1u3q 
Crystal Structure of Estrogen Receptor beta complexed with CL-272 1u3r 
Crystal Structure of Estrogen Receptor beta complexed with WAY-338 1u3s 
Crystal Structure of Estrogen Receptor beta complexed with WAY-797 1u9e 
CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-397 1uhl 
Crystal structure of the LXRalfa-RXRbeta LBD heterodimer 1uom 
The Structure of Estrogen Receptor in Complex with a Selective and Potent Tetrahydroisochiolin Ligand. 1upv 
Crystal structure of the human Liver X receptor beta ligand binding domain in complex with a synthetic agonist 1upw 
Crystal structure of the human Liver X receptor beta ligand binding domain in complex with a synthetic agonist 1vjb 
crystal structure of the ligand-binding domain of the estrogen-related receptor gamma in complex with 4-hydroxytamoxifen 1wm0 
PPARgamma in complex with a 2-BABA compound 1x76 
CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-697 1x78 
CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-244 1x7b 
CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH ERB-041 1x7e 
CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR ALPHA COMPLEXED WITH WAY-244 1x7j 
CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH GENISTEIN 1x7r 
CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR ALPHA COMPLEXED WITH GENISTEIN 1xap 
Structure of the ligand binding domain of the Retinoic Acid Receptor beta 1xb7 
X-ray structure of ERRalpha LBD in complex with a PGC-1alpha peptide at 2.5A resolution 1xdk 
Crystal Structure of the RARbeta/RXRalpha Ligand Binding Domain Heterodimer in Complex with 9-cis Retinoic Acid and a Fragment of the TRAP220 Coactivator 1xiu 
Crystal structure of the agonist-bound ligand-binding domain of Biomphalaria glabrata RXR 1xj7 
Complex Androgen Receptor LBD and RAC3 peptide 1xls 
Crystal structure of the mouse CAR/RXR LBD heterodimer bound to TCPOBOP and 9cRA and a TIF2 peptide containg the third LXXLL motifs 1xnn 
CRYSTAL STRUCTURE OF THE RAT ANDROGEN RECEPTOR LIGAND BINDING DOMAIN T877A MUTANT COMPLEX WITH (3A-ALPHA-,4-ALPHA 7-ALPHA-,7A-ALPHA-)-3A,4,7,7A-TETRAHYDRO-2-(4-NITRO-1-NAPHTHALENYL)-4,7-ETHANO-1H-ISOINDOLE-1,3(2H)-DIONE. 1xnx 
Crystal structure of constitutive androstane receptor 1xow 
Crystal structure of the human androgen receptor ligand binding domain bound with an androgen receptor NH2-terminal peptide, AR20-30, and R1881 1xp1 
HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 15 1xp6 
HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 16 1xp9 
HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 18 1xpc 
HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 19 1xq3 
Crystal structure of the human androgen receptor ligand binding domain bound with R1881 1xqc 
X-ray structure of ERalpha LBD bound to a tetrahydroisoquinoline SERM ligand at 2.05A resolution 1xv9 
crystal structure of CAR/RXR heterodimer bound with SRC1 peptide, fatty acid, and 5b-pregnane-3,20-dione. 1xvp 
crystal structure of CAR/RXR heterodimer bound with SRC1 peptide, fatty acid and CITCO 1xzx 
Thyroxine-Thyroid Hormone Receptor Interactions 1y0s 
Crystal structure of PPAR delta complexed with GW2331 1y0x 
Thyroxine-Thyroid Hormone Receptor Interactions 1y9r 
Crystal structure of the human mineralocorticoid receptor ligand-binding domain bound to deoxycorticosterone and harboring the S810L mutation responsible for a severe form of hypertension 1ya3 
Crystal structure of the human mineralocorticoid receptor ligand-binding domain bound to progesterone and harboring the S810L mutation responsible for a severe form of hypertension 1yim 
Human estrogen receptor alpha ligand-binding domain in complex with compound 4 1yin 
Human estrogen receptor alpha ligand-binding domain in complex with compound 3F 1yje 
Crystal structure of the rNGFI-B ligand-binding domain 1ymt 
Mouse SF-1 LBD 1yok 
crystal structure of human LRH-1 bound with TIF-2 peptide and phosphatidylglycerol 1yow 
human Steroidogenic Factor 1 LBD with bound Co-factor Peptide 1yp0 
Structure of the steroidogenic factor-1 ligand binding domain bound to phospholipid and a SHP peptide motif 1yuc 
Human Nuclear Receptor Liver Receptor Homologue-1, LRH-1, Bound to Phospholipid and a Fragment of Human SHP 1yy4 
Crystal structure of estrogen receptor beta complexed with 1-chloro-6-(4-hydroxy-phenyl)-naphthalen-2-ol 1yye 
Crystal structure of estrogen receptor beta complexed with way-202196 1z5x 
hemipteran ecdysone receptor ligand-binding domain complexed with ponasterone A 1z95 
Crystal Structure of the Androgen Receptor Ligand-binding Domain W741L Mutant Complex with R-bicalutamide 1zaf 
Crystal structure of estrogen receptor beta complexed with 3-Bromo-6-hydroxy-2-(4-hydroxy-phenyl)-inden-1-one 1zdt 
The Crystal Structure of Human Steroidogenic Factor-1 1zdu 
The Crystal Structure of Human Liver Receptor Homologue-1 1zeo 
Crystal Structure of Human PPAR-gamma Ligand Binding Domain Complexed with an Alpha-Aryloxyphenylacetic Acid Agonist 1zgy 
Structural and Biochemical Basis for Selective Repression of the Orphan Nuclear Receptor LRH-1 by SHP 1zh7 
Structural and Biochemical Basis for Selective Repression of the Orphan Nuclear Receptor LRH-1 by SHP 1zky 
Human Estrogen Receptor Alpha Ligand-Binding Domain In Complex With OBCP-3M and A Glucocorticoid Receptor Interacting Protein 1 Nr Box II Peptide 1zuc 
Progesterone receptor ligand binding domain in complex with the nonsteroidal agonist tanaproget 2a3i 
Structural and Biochemical Mechanisms for the Specificity of Hormone Binding and Coactivator Assembly by Mineralocorticoid Receptor 2aa2 
Mineralocorticoid Receptor with Bound Aldosterone 2aa5 
Mineralocorticoid Receptor with Bound Progesterone 2aa6 
Mineralocorticoid Receptor S810L Mutant with Bound Progesterone 2aa7 
Mineralocorticoid Receptor with Bound Deoxycorticosterone 2aax 
Mineralocorticoid Receptor Double Mutant with Bound Cortisone 2ab2 
Mineralocorticoid Receptor Double Mutant with Bound Spironolactone 2abi 
Crystal structure of the human mineralocorticoid receptor ligand-binding domain bound to deoxycorticosterone 2acl 
Liver X-Receptor alpha Ligand Binding Domain with SB313987 2am9 
Crystal structure of human androgen receptor ligand binding domain in complex with testosterone 2ama 
Crystal structure of human androgen receptor ligand binding domain in complex with dihydrotestosterone 2amb 
Crystal structure of human androgen receptor ligand binding domain in complex with tetrahydrogestrinone 2ao6 
Crystal structure of the human androgen receptor ligand binding domain bound with TIF2(iii) 740-753 peptide and R1881 2ath 
Crystal structure of the ligand binding domain of human PPAR-gamma im complex with an agonist 2awh 
Human Nuclear Receptor-Ligand Complex 1 2ax6 
Crystal Structure Of The Androgen Receptor Ligand Binding Domain T877A Mutant In Complex With Hydroxyflutamide 2ax7 
Crystal Structure Of The Androgen Receptor Ligand Binding Domain T877A Mutant In Complex With S-1 2ax8 
Crystal Structure Of The Androgen Receptor Ligand Binding Domain W741L Mutant In Complex With S-1 2ax9 
Crystal Structure Of The Androgen Receptor Ligand Binding Domain In Complex With R-3 2axa 
Crystal Structure Of The Androgen Receptor Ligand Binding Domain In Complex With S-1 2ayr 
A SERM Designed for the Treatment of Uterine Leiomyoma with Unique Tissue Specificity for Uterus and Ovaries in Rats 2b1v 
Human estrogen receptor alpha ligand-binding domain in complex with OBCP-1M and a glucocorticoid receptor interacting protein 1 NR box II peptide 2b1z 
Human estrogen receptor alpha ligand-binding domain in complex with 17methyl-17alpha-dihydroequilenin and a glucoc interacting protein 1 NR box II peptide 2b23 
Human estrogen receptor alpha ligand-binding domain and a glucocorticoid receptor-interacting protein 1 NR box II peptide 2b50 
Human Nuclear Receptor-Ligand Complex 2 2baw 
Human Nuclear Receptor-Ligand Complex 1 2bj4 
ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH A PHAGE-DISPLAY DERIVED PEPTIDE ANTAGONIST 2e2r 
Crystal structure of human estrogen-related receptor gamma ligand binding domain complex with bisphenol A 2ewp 
Crystal structure of Estrogen Related Receptor-3 (ERR-gamma) ligand binding domaind with tamoxifen analog GSK5182 2f4b 
Crystal structure of the ligand binding domain of human PPAR-gamma in complex with an agonist 2fai 
Human Estrogen Receptor Alpha Ligand-Binding Domain In Complex With OBCP-2M and A Glucocorticoid Receptor Interacting Protein 1 NR Box II Peptide 2fsz 
A second binding site for hydroxytamoxifen within the coactivator-binding groove of estrogen receptor beta 2fvj 
A novel anti-adipogenic partial agonist of peroxisome proliferator-activated receptor-gamma (PPARG) recruits pparg-coactivator-1 alpha (PGC1A) but potentiates insulin signaling in vitro 2g0g 
Structure-based drug design of a novel family of PPAR partial agonists: virtual screening, x-ray crystallography and in vitro/in vivo biological activities 2g0h 
Structure-based drug design of a novel family of PPAR partial agonists: virtual screening, x-ray crystallography and in vitro/in vivo biological activities 2g44 
Human Estrogen Receptor Alpha Ligand-Binding Domain In Complex With OBCP-1M-G and A Glucocorticoid Receptor Interacting Protein 1 NR Box II Peptide 2g5o 
Human estrogen receptor alpha ligand-binding domain in complex with 2-(but-1-enyl)-17beta-estradiol and a glucocorticoid receptor interacting protein 1 NR BOX II Peptide 2giu 
Human estrogen receptor beta ligand-binding domain in complex with compound 45 2gl8 
Human Retinoic acid receptor RXR-gamma ligand-binding domain 2gp7 
Estrogen Related Receptor-gamma ligand binding domain 2gpo 
Estrogen Related Receptor-gamma ligand binding domain complexed with a synthetic peptide from RIP140 2gpp 
Estrogen Related Receptor-gamma ligand binding domain complexed with a RIP140 peptide and synthetic ligand GSK4716 2gpu 
Estrogen Related Receptor-gamma ligand binding domain complexed with 4-hydroxy-tamoxifen 2gpv 
Estrogen Related Receptor-gamma ligand binding domain complexed with 4-hydroxy-tamoxifen and a SMRT peptide 2gtk 
Structure-based Design of Indole Propionic Acids as Novel PPARag CO-Agonists 2gwx 
MOLECULAR RECOGNITION OF FATTY ACIDS BY PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS 2h77 
Crystal structure of human TR alpha bound T3 in monoclinic space group 2h79 
Crystal Structure of human TR alpha bound T3 in orthorhombic space group 2ham 
Crystal structure of VDR LBD complexed to 2alpha-propyl-calcitriol 2har 
Crystal structure of VDR LBD in complex with 2 alpha-(3-hydroxy-1-propoxy) calcitriol 2has 
Crystal structure of VDR LBD in complex with 2alpha-(1-propoxy) calcitriol 2hb7 
Crystal structure of VDR LBD in complex with 2alpha(3-hydroxy-1-propyl) calcitriol 2hb8 
Crystal structure of VDR LBD in complex with 2alpha-methyl calcitriol 2hbh 
Crystal structure of Vitamin D nuclear receptor ligand binding domain bound to a locked side-chain analog of calcitriol and SRC-1 peptide 2hc4 
Crystal structure of the LBD of VDR of Danio rerio in complex with calcitriol 2hcd 
Crystal structure of the ligand binding domain of the Vitamin D nuclear receptor in complex with Gemini and a coactivator peptide 2hfp 
Crystal Structure of PPAR Gamma with N-sulfonyl-2-indole carboxamide ligands 2hvc 
The Crystal Structure of Ligand-binding Domain (LBD) of human Androgen Receptor in Complex with a selective modulator LGD2226 2hwq 
Structural basis for the structure-activity relationships of Peroxisome Proliferator-Activated Receptor agonists 2hwr 
Structural basis for the structure-activity relationships of Peroxisome Proliferator-Activated Receptor agonists 2i0g 
Benzopyrans are Selective Estrogen Receptor beta Agonists (SERBAs) with Novel Activity in Models of Benign Prostatic Hyperplasia 2i0j 
Benzopyrans are Selective Estrogen Receptor beta Agonists (SERBAs) with Novel Activity in Models of Benign Prostatic Hyperplasia 2i4j 
Crystal structure of the complex between PPARgamma and the agonist LT160 (ureidofibrate derivative) 2i4p 
Crystal structure of the complex between PPARgamma and the partial agonist LT127 (ureidofibrate derivative). Structure obtained from crystals of the apo-form soaked for 30 days. 2i4z 
Crystal structure of the complex between PPARgamma and the partial agonist LT127 (ureidofibrate derivative). This structure has been obtained from crystals soaked for 6 hours. 2ihq 
Crystal Structure of the Rat Androgen Receptor Ligand Binding Domian Complex with an N-Aryl-Hydroxybicyclohydantoin 2iog 
Human estrogen receptor alpha ligand-binding domain in complex with compound 11F 2iok 
Human estrogen receptor alpha ligand-binding domain in complex with compound 1D 2j14 
3,4,5-Trisubstituted Isoxazoles as Novel PPARdelta Agonists: Part2 2j4a 
Human Thyroid hormone receptor beta ligand binding domain in complex with KB131084 2j7x 
STRUCTURE OF ESTRADIOL-BOUND ESTROGEN RECEPTOR BETA LBD IN COMPLEX WITH LXXLL MOTIF FROM NCOA5 2j7y 
STRUCTURE OF 17-EPIESTRIOL-BOUND ESTROGEN RECEPTOR BETA LBD IN COMPLEX WITH LXXLL MOTIF FROM NCOA5 2jf9 
ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH A TAMOXIFEN-SPECIFIC PEPTIDE ANTAGONIST 2jfa 
ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH AN AFFINITY-SELECTED COREPRESSOR PEPTIDE 2jj3 
Estrogen receptor beta ligand binding domain in complex with a Benzopyran agonist 2lbd 
LIGAND-BINDING DOMAIN OF THE HUMAN RETINOIC ACID RECEPTOR GAMMA BOUND TO ALL-TRANS RETINOIC ACID 2npa 
the crystal structure of the human PPARaplpha ligand binding domain in complex with a a-hydroxyimino phenylpropanoic acid 2nv7 
Crystal Structure of Estrogen Receptor Beta Complexed with WAY-555 2nw4 
Crystal Structure of the Rat Androgen Receptor Ligand Binding Domain Complex with BMS-564929 2nxx 
Crystal Structure of the Ligand-Binding Domains of the T.castaneum (Coleoptera) Heterodimer EcrUSP Bound to Ponasterone A 2o4j 
Crystal Structure of Rat Vitamin D Receptor Ligand Binding Domain Complexed with VitIII 17-20Z and the NR2 Box of DRIP 205 2o4r 
Crystal Structure of Rat Vitamin D Receptor Ligand Binding Domain Complexed with VitIII 17-20E and the NR2 Box of DRIP 205 2o9i 
Crystal Structure of the Human Pregnane X Receptor LBD in complex with an SRC-1 coactivator peptide and T0901317 2oax 
Crystal structure of the S810L mutant mineralocorticoid receptor associated with SC9420 2ocf 
Human estrogen receptor alpha ligand-binding domain in complex with estradiol and the E2#23 FN3 monobody 2om9 
Ajulemic acid, a synthetic cannabinoid bound to PPAR gamma 2ouz 
Crystal Structure of Estrogen Receptor alpha-lasofoxifene complex 2ovh 
Progesterone Receptor with Bound Asoprisnil and a Peptide from the Co-Repressor SMRT 2ovm 
Progesterone Receptor with Bound Asoprisnil and a Peptide from the Co-Repressor NCoR 2oz7 
Crystal structure of the human androgen receptor T877A mutant ligand-binding domain with cyproterone acetate 2p15 
Crystal structure of the ER alpha ligand binding domain with the agonist ortho-trifluoromethylphenylvinyl estradiol 2p1t 
Crystal structure of the ligand binding domain of the retinoid X receptor alpha in complex with 3-(2'-methoxy)-tetrahydronaphtyl cinnamic acid and a fragment of the coactivator TIF-2 2p1u 
Crystal structure of the ligand binding domain of the retinoid X receptor alpha in complex with 3-(2'-ethoxy)-tetrahydronaphtyl cinnamic acid and a fragment of the coactivator TIF-2 2p1v 
Crystal structure of the ligand binding domain of the retinoid X receptor alpha in complex with 3-(2'-propoxy)-tetrahydronaphtyl cinnamic acid and a fragment of the coactivator TIF-2 2p4y 
Crystal structure of human PPAR-gamma-ligand binding domain complexed with an indole-based modulator 2p54 
a crystal structure of PPAR alpha bound with SRC1 peptide and GW735 2p7a 
Crystal Structure of Estrogen Related Receptor g in complex with 3-methyl phenol 2p7g 
X-ray Structure of Estrogen Related Receptor g in complex with Bisphenol A. 2p7z 
Estrogen Related Receptor Gamma in complex with 4-hydroxy-tamoxifen 2pin 
Thyroid receptor beta in complex with inhibitor 2pio 
Androgen receptor LBD with small molecule 2pip 
Androgen receptor LBD with small molecule 2piq 
androgen receptor LBD with small molecule 2pir 
Androgen receptor LBD with small molecule 2pit 
Androgen receptor LBD with small molecule 2piu 
Androgen receptor LBD with small molecule 2piv 
Androgen receptor with small molecule 2piw 
Androgen receptor with small molecule 2pix 
AR LBD with small molecule 2pjl 
Crystal Structure of Human Estrogen-Related Receptor alpha in Complex with a Synthetic Inverse Agonist reveals its Novel Molecular Mechanism 2pkl 
Androgen receptor LBD with small molecule 2pnu 
Crystal structure of human androgen receptor ligand-binding domain in complex with EM-5744 2pob 
PPARgamma Ligand binding domain complexed with a farglitazar analogue gw4709 2pog 
Benzopyrans as Selective Estrogen Receptor b Agonists (SERBAs). Part 2: Structure Activity Relationship Studies on the Benzopyran Scaffold. 2prg 
LIGAND-BINDING DOMAIN OF THE HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2q1h 
Ancestral Corticoid Receptor in Complex with Aldosterone 2q1v 
Ancestral corticoid receptor in complex with cortisol 2q3y 
Ancestral Corticiod Receptor in Complex with DOC 2q59 
Crystal Structure of PPARgamma LBD bound to full agonist MRL20 2q5g 
Ligand binding domain of PPAR delta receptor in complex with a partial agonist 2q5p 
Crystal Structure of PPARgamma bound to partial agonist MRL24 2q5s 
Crystal Structure of PPARgamma bound to partial agonist nTZDpa 2q60 
Crystal structure of the ligand binding domain of polyandrocarpa misakiensis rxr in tetramer in absence of ligand 2q61 
Crystal Structure of PPARgamma ligand binding domain bound to partial agonist SR145 2q6j 
Crystal Structure of Estrogen Receptor alpha Complexed to a B-N Substituted Ligand 2q6r 
Crystal structure of PPAR gamma complexed with partial agonist SF147 2q6s 
2.4 angstrom crystal structure of PPAR gamma complexed to BVT.13 without co-activator peptides 2q70 
Estrogen receptor alpha ligand-binding domain complxed to a benzopyran ligand 2q7i 
The Wild Type Androgen Receptor Ligand Binding Domain Bound with Testosterone and an AR 20-30 Peptide 2q7j 
The Wild Type Androgen Receptor Ligand Binding Domain Bound with Testosterone and a TIF2 box 3 Coactivator Peptide 740-753 2q7k 
The Androgen Receptor Prostate Cancer Mutant H874Y Ligand Binding Domain Bound with Testosterone and an AR 20-30 Peptide 2q7l 
The Androgen Receptor Prostate Cancer Mutant H874Y Ligand Binding Domain Bound with Testosterone and a TIF2 box3 Coactivator Peptide 740-753 2q8s 
X-ray Crystal structure of the nuclear hormone receptor PPAR-gamma in a complex with a PPAR gamma/alpha dual agonist 2qa6 
Crystal Structure of Estrogen Receptor Alpha mutant 537S Complexed with 4-(6-hydroxy-1H-indazol-3-yl)benzene-1,3-diol 2qa8 
Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Mutant 537S Complexed with Genistein 2qab 
Crystal Structure of Estrogen Receptor Alpha Ligand Binding Domain Mutant 537S Complexed with an Ethyl Indazole Compound 2qe4 
Estrogen receptor alpha ligand-binding domain in complex with a benzopyran agonist 2qgt 
Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Complexed to an Ether Estradiol Compound 2qgw 
Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Complexed with a Chloro-Indazole Compound 2qh6 
Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Complexed with an Oxabicyclic diarylethylene Compound 2qmv 
High Resolution Structure of Peroxisone Proliferation-Activated Receptor gamma and Characterisation of its Interaction with the Co-activator Transcriptional Intermediary Factor 2 2qnv 
Crystal Structure of the Pregnane X Receptor bound to Colupulone 2qpy 
AR LBD with small molecule 2qr9 
Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Complexed with an Oxabicyclic Derivative Compound 2qse 
Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain complexed with Burned Meat Compound 4-OH-PhIP 2qtu 
Estrogen receptor beta ligand-binding domain complexed to a benzopyran ligand 2qw4 
Human NR4A1 ligand-binding domain 2qxm 
Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Complexed to Burned Meat Compound PhIP 2qxs 
Crystal Structure of Antagonizing Mutant 536S of the Estrogen Receptor Alpha Ligand Binding Domain Complexed to Raloxifene 2qzo 
Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Complexed with WAY-169916 2r40 
Crystal structure of 20E bound EcR/USP 2r6w 
Estrogen receptor alpha ligand-binding domain complexed to a SERM 2r6y 
Estrogen receptor alpha ligand-binding domain in complex with a SERM 2rew 
Crystal Structure of PPARalpha ligand binding domain with BMS-631707 2v0v 
Crystal Structure of Rev-Erb beta 2v7c 
Crystal Structure of Rev-Erb beta 2vsr 
hPPARgamma Ligand binding domain in complex with 9-(S)-HODE 2vst 
hPPARgamma Ligand binding domain in complex with 13-(S)-HODE 2vv0 
hPPARgamma Ligand binding domain in complex with DHA 2vv1 
hPPARgamma Ligand binding domain in complex with 4-HDHA 2vv2 
hPPARgamma Ligand binding domain in complex with 5-HEPA 2vv3 
hPPARgamma Ligand binding domain in complex with 4-oxoDHA 2vv4 
hPPARgamma Ligand binding domain in complex with 6-oxoOTE 2w8y 
RU486 bound to the progesterone receptor in a destabilized agonistic conformation 2xhs 
Crystal structure of the ligand binding domain of Fushi tarazu factor 1 of Drosophila melanogaster. 2xkw 
LIGAND BINDING DOMAIN OF HUMAN PPAR-GAMMA IN COMPLEX WITH THE AGONIST PIOGLITAZONE 2xyj 
Novel Sulfonylthiadiazoles with an Unusual Binding Mode as Partial Dual Peroxisome Proliferator-Activated Receptor (PPAR) gamma-delta Agonists with High Potency and In-vivo Efficacy 2xyw 
Novel Sulfonylthiadiazoles with an Unusual Binding Mode as Partial Dual Peroxisome Proliferator-Activated Receptor (PPAR) gamma-delta Agonists with High Potency and In-vivo Efficacy 2xyx 
Novel Sulfonylthiadiazoles with an Unusual Binding Mode as Partial Dual Peroxisome Proliferator-Activated Receptor (PPAR) gamma-delta Agonists with High Potency and In-vivo Efficacy 2yat 
Crystal structure of estradiol derived metal chelate and estrogen receptor-ligand binding domain complex 2yfe 
Ligand binding domain of human PPAR gamma in complex with amorfrutin 1 2yhd 
Human androgen receptor in complex with AF2 small molecule inhibitor 2yja 
Stapled Peptides binding to Estrogen Receptor alpha. 2yjd 
Stapled peptide bound to Estrogen Receptor Beta 2ylo 
TARGETING THE BINDING FUNCTION 3 SITE OF THE ANDROGEN RECEPTOR THROUGH IN SILICO MOLECULAR MODELING 2ylp 
TARGETING THE BINDING FUNCTION 3 SITE OF THE ANDROGEN RECEPTOR THROUGH IN SILICO MOLECULAR MODELING 2ylq 
TARGETING THE BINDING FUNCTION 3 SITE OF THE ANDROGEN RECEPTOR THROUGH IN SILICO MOLECULAR MODELING 2yly 
Sulfonamides as selective Estrogen Receptor beta Agonists. 2z4b 
Estrogen receptor beta ligand-binding domain complexed to a benzopyran ligand 2z4j 
Crystal structure of AR LBD with SHP peptide NR Box 2 2zas 
Crystal structure of human estrogen-related receptor gamma ligand binding domain complex with 4-alpha-cumylphenol, a bisphenol A derivative 2zbs 
Crystal structure of human estrogen-related receptor gamma ligand binding domain apo form 2zfx 
Crystal structure of the rat vitamin D receptor ligand binding domain complexed with YR301 and a synthetic peptide containing the NR2 box of DRIP 205 2zk0 
Human peroxisome proliferator-activated receptor gamma ligand binding domain 2zk1 
Human peroxisome proliferator-activated receptor gamma ligand binding domain complexed with 15-deoxy-delta12,14-prostaglandin J2 2zk2 
Human peroxisome proliferator-activated receptor gamma ligand binding domain complexed with glutathion conjugated 15-deoxy-delta12,14-prostaglandin J2 2zk3 
Human peroxisome proliferator-activated receptor gamma ligand binding domain complexed with 8-oxo-eicosatetraenoic acid 2zk4 
Human peroxisome proliferator-activated receptor gamma ligand binding domain complexed with 15-oxo-eicosatetraenoic acid 2zk5 
Human peroxisome proliferator-activated receptor gamma ligand binding domain complexed with nitro-233 2zk6 
Human peroxisome proliferator-activated receptor gamma ligand binding domain complexed with C8-BODIPY 2zkc 
Crystal structure of human estrogen-related receptor gamma ligand binding domain complex with bisphenol Z 2zl9 
2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation and crystal structure 2zla 
2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation and crystal structure 2zlc 
2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation and crystal structure 2zmh 
Crystal Structure of Rat Vitamin D Receptor Bound to Adamantyl Vitamin D Analogs: Structural Basis for Vitamin D Receptor Antagonism and/or Partial Agonism 2zmi 
Crystal Structure of Rat Vitamin D Receptor Bound to Adamantyl Vitamin D Analogs: Structural Basis for Vitamin D Receptor Antagonism and/or Partial Agonism 2zmj 
Crystal Structure of Rat Vitamin D Receptor Bound to Adamantyl Vitamin D Analogs: Structural Basis for Vitamin D Receptor Antagonism and/or Partial Agonism 2znn 
Human PPRR alpha ligand binding domain in complex with a synthetic agonist TIPP703 2zno 
Human PPRR gamma ligand binding domain in complex with a synthetic agonist TIPP703 2znp 
Human PPRR delta ligand binding domain in complex with a synthetic agonist TIPP204 2znq 
Human PPRR delta ligand binding domain in complex with a synthetic agonist TIPP401 2zvt 
Cys285Ser mutant PPARgamma ligand-binding domain complexed with 15-deoxy-delta12,14-prostaglandin J2 2zxm 
A New Class of Vitamin D Receptor Ligands that Induce Structural Rearrangement of the Ligand-binding Pocket 2zxn 
A New Class of Vitamin D Receptor Ligands that Induce Structural Rearrangement of the Ligand-binding Pocket 2zxz 
Crystal structure of the human RXR alpha ligand binding domain bound to a synthetic agonist compound and a coactivator peptide 2zy0 
Crystal structure of the human RXR alpha ligand binding domain bound to a synthetic agonist compound and a coactivator peptide 3a2h 
Crystal structure of the rat vitamin D receptor ligand binding domain complexed with TEI-9647 and a synthetic peptide containing the NR2 box of DRIP 205 3a2i 
Crystal structure of the human vitamin D receptor (H305F) ligand binding domain complexed with TEI-9647 3a2j 
Crystal structure of the human vitamin D receptor (H305F/H397F) ligand binding domain complexed with TEI-9647 3a3z 
Crystal structure of the human VDR ligand binding domain bound to the synthetic agonist compound 2alpha-methyl-AMCR277A(C23S) 3a40 
Crystal structure of the human VDR ligand binding domain bound to the synthetic agonist compound 2alpha-methyl-AMCR277B(C23R) 3a78 
Crystal structure of the human VDR ligand binding domain bound to the natural metabolite 1alpha,25-dihydroxy-3-epi-vitamin D3 3a9e 
Crystal structure of a mixed agonist-bound RAR-alpha and antagonist-bound RXR-alpha heterodimer ligand binding domains 3ads 
Human PPARgamma ligand-binding domain in complex with indomethacin 3adt 
Human PPARgamma ligand-binding domain in complex with 5-hydroxy-indole acetate 3adu 
Human PPARgamma ligand-binding domain in complex with 5-methoxy-indole acetate 3adv 
Human PPARgamma ligand-binding domain in complex with serotonin 3adw 
Human PPARgamma ligand-binding domain in complex with 5-methoxy-indole acetate and 15-oxo-eicosatetraenoic acid 3adx 
Human PPARgamma ligand-binding domain in complex with indomethacin and nitro-233 3afr 
Crystal Structure of VDR-LBD/22S-Butyl-1a,24R-dihydroxyvitamin D3 complex 3an3 
Human PPAR gamma ligand binding domain in complex with a gamma selective agonist MO3S 3an4 
Human PPAR gamma ligand binding domain in complex with a gamma selective agonist MO4R 3aun 
Crystal structure of the rat vitamin D receptor ligand binding domain complexed with YR335 and a synthetic peptide containing the NR2 box of DRIP 205 3auq 
Crystal structure of the human vitamin D receptor ligand binding domain complexed with Yne-diene type analog of active 14-epi-2alpha-methyl-19-norvitamin D3 3aur 
Crystal structure of the human vitamin D receptor ligand binding domain complexed with Yne-diene type analog of active 14-epi-2beta-methyl-19-norvitamin D3 3ax8 
Crystal structure of the human vitamin D receptor ligand binding domain complexed with 15alpha-methoxy-1alpha,25-dihydroxyvitamin D3 3az1 
Crystal Structure Analysis of Vitamin D receptor 3az2 
Crystal Structure Analysis of Vitamin D receptor 3az3 
Crystal Structure Analysis of Vitamin D receptor 3b0q 
Human PPAR gamma ligand binding domain in complex with MCC555 3b0r 
Human PPAR gamma ligand binding dmain complexed with GW9662 in a covalent bonded form 3b0t 
Human VDR ligand binding domain in complex with maxacalcitol 3b0w 
Crystal structure of the orphan nuclear receptor ROR(gamma)t ligand-binding domain in complex with digoxin 3b1m 
Crystal structure of the PPARgamma-LBD complexed with a cercosporamide derivative modulator Cerco-A 3b3k 
Crystal structure of the complex between PPARgamma and the full agonist LT175 3b5r 
Crystal structure of the androgen receptor ligand binding domain in complex with SARM C-31 3b65 
Crystal structure of the androgen receptor ligand binding domain in complex with SARM S-24 3b66 
Crystal structure of the androgen receptor ligand binding domain in complex with SARM S-21 3b67 
Crystal structure of the androgen receptor ligand binding domain in complex with SARM C-23 3b68 
Crystal structure of the androgen receptor ligand binding domain in complex with SARM S-4 3bc5 
X-ray crystal structure of human ppar gamma with 2-(5-(3-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)benzyl)-2-phenyl-2h-1,2,3-triazol-4-yl)acetic acid 3bej 
Structure of human FXR in complex with MFA-1 and co-activator peptide 3bqd 
Doubling the Size of the Glucocorticoid Receptor Ligand Binding Pocket by Deacylcortivazol 3cdp 
Crystal structure of PPAR-gamma LBD complexed with a partial agonist, analogue of clofibric acid 3cds 
Crystal structure of the complex between PPAR-gamma and the agonist LT248 (clofibric acid analogue) 3cjw 
Crystal structure of the human COUP-TFII ligand binding domain 3cld 
Ligand binding domain of the glucocorticoid receptor complexed with fluticazone furoate 3cqv 
Crystal structure of Reverb beta in complex with heme 3cs4 
Structure-based design of a superagonist ligand for the vitamin D nuclear receptor 3cs6 
Structure-based design of a superagonist ligand for the vitamin D nuclear receptor 3cs8 
Structural and Biochemical Basis for the Binding Selectivity of PPARg to PGC-1a 3ctb 
Tethered PXR-LBD/SRC-1p apoprotein 3cwd 
Molecular recognition of nitro-fatty acids by PPAR gamma 3d24 
Crystal structure of ligand-binding domain of estrogen-related receptor alpha (ERRalpha) in complex with the peroxisome proliferators-activated receptor coactivator-1alpha box3 peptide (PGC-1alpha) 3d57 
TR Variant D355R 3d5f 
Crystal Structure of PPAR-delta complex 3d6d 
Crystal Structure of the complex between PPARgamma LBD and the LT175(R-enantiomer) 3d90 
Crystal structure of the human progesterone receptor ligand-binding domain bound to levonorgestrel 3dct 
FXR with SRC1 and GW4064 3dcu 
FXR with SRC1 and GSK8062 3dr1 
Side-chain fluorine atoms of non-steroidal vitamin D3 analogs stabilize helix 12 of vitamin D receptor 3dt3 
Human Estrogen receptor alpha LBD with GW368 3dy6 
PPARdelta complexed with an anthranilic acid partial agonist 3dzu 
Intact PPAR gamma - RXR alpha Nuclear Receptor Complex on DNA bound with BVT.13, 9-cis Retinoic Acid and NCOA2 Peptide 3dzy 
Intact PPAR gamma - RXR alpha Nuclear Receptor Complex on DNA bound with Rosiglitazone, 9-cis Retinoic Acid and NCOA2 Peptide 3e00 
Intact PPAR gamma - RXR alpha Nuclear Receptor Complex on DNA bound with GW9662, 9-cis Retinoic Acid and NCOA2 Peptide 3e7c 
Glucocorticoid Receptor LBD bound to GSK866 3e94 
Crystal structure of RXRalpha ligand binding domain in complex with tributyltin and a coactivator fragment 3erd 
HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH DIETHYLSTILBESTROL AND A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE 3ert 
HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH 4-HYDROXYTAMOXIFEN 3et0 
Structure of PPARgamma with 3-(5-Methoxy-1H-indol-3-yl)-propionic acid 3et1 
Structure of PPARalpha with 3-[5-Methoxy-1-(4-methoxy-benzenesulfonyl)-1H-indol-3-yl]-propionic acid 3et2 
Structure of PPARdelta with 3-[5-Methoxy-1-(4-methoxy-benzenesulfonyl)-1H-indol-3-yl]-propionic acid 3et3 
Structure of PPARgamma with 3-[5-Methoxy-1-(4-methoxy-benzenesulfonyl)-1H-indol-3-yl]-propionic acid 3eyb 
Structural and functional insights into the ligand binding domain of a non-duplicated RXR from the invertebrate chordate amphioxus 3f5c 
Structure of Dax-1:LRH-1 complex 3f7d 
SF-1 LBD bound by phosphatidylcholine 3fal 
humanRXR alpha & mouse LXR alpha complexed with Retenoic acid and GSK2186 3fc6 
hRXRalpha & mLXRalpha with an indole Pharmacophore, SB786875 3fei 
Design and biological evaluation of novel, balanced dual PPARa/g agonists 3fej 
Design and biological evaluation of novel, balanced dual PPARa/g agonists 3fli 
Discovery of XL335, a Highly Potent, Selective and Orally-Active Agonist of the Farnesoid X Receptor (FXR) 3fs1 
Crystal structure of HNF4a LBD in complex with the ligand and the coactivator PGC-1a fragment 3fug 
Crystal Structure of the Retinoid X Receptor Ligand Binding Domain Bound to the Synthetic Agonist 3-[4-Hydroxy-3-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-phenyl]acrylic Acid 3fur 
Crystal Structure of PPARg in complex with INT131 3fxv 
Identification of an N-oxide pyridine GW4064 analogue as a potent FXR agonist 3g0w 
Crystal structure of the rat androgen receptor ligand binding domain complex with an n-aryl-oxazolidin 2-imine inhibitor 3g8i 
Aleglitazar, a new, potent, and balanced PPAR alpha/gamma agonist for the treatment of type II diabetes 3g8o 
Progesterone Receptor with bound Pyrrolidine 1 3g9e 
Aleglitaar. a new. potent, and balanced dual ppara/g agonist for the treatment of type II diabetes 3gbk 
Crystal Structure of Human PPAR-gamma Ligand Binding Domain Complexed with a Potent and Selective Agonist 3gd2 
isoxazole ligand bound to farnesoid X receptor (FXR) 3gn8 
X-ray Crystal Structure of AncGR2 in Complex with Dexamethasone 3gws 
Crystal Structure of T3-Bound Thyroid Hormone Receptor 3gwx 
MOLECULAR RECOGNITION OF FATTY ACIDS BY PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS 3gyt 
Nuclear receptor DAF-12 from parasitic nematode Strongyloides stercoralis in complex with its physiological ligand dafachronic acid delta 4 3gyu 
Nuclear receptor DAF-12 from parasitic nematode Strongyloides stercoralis in complex with its physiological ligand dafachronic acid delta 7 3gz9 
Crystal Structure of Peroxisome Proliferator-Activated Receptor Delta (PPARd) in Complex with a Full Agonist 3h0a 
Crystal Structure of Peroxisome Proliferator-Activated Receptor Gamma (PPARg) and Retinoic Acid Receptor Alpha (RXRa) in Complex with 9-cis Retinoic Acid, Co-activator Peptide, and a Partial Agonist 3h52 
Crystal structure of the antagonist form of human glucocorticoid receptor 3hc5 
FXR with SRC1 and GSK826 3hc6 
FXR with SRC1 and GSK088 3hlv 
Crystal structure of human Estrogen Receptor Alpha Ligand-Binding Domain in complex with a Glucocorticoid Receptor Interacting Protein 1 Nr Box II Peptide and 16-alpha-hydroxy-estrone ((8S,9R,13S,14R,16R)-3,16-dihydroxy-13-methyl-7,8,9,11,12,14,15, 16-octahydro-6H-cyclopenta[a]phenanthren-17-one 3hm1 
Crystal structure of human Estrogen Receptor Alpha Ligand-Binding Domain in complex with a Glucocorticoid Receptor Interacting Protein 1 Nr Box II Peptide and estrone ((8R,9S,13S,14S)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one) 3ho0 
Crystal structure of the PPARgamma-LBD complexed with a new aryloxy-3phenylpropanoic acid 3hod 
Crystal structure of the PPARgamma-LBD complexed with a new aryloxy-3phenylpropanoic acid 3hq5 
Progesterone Receptor bound to an Alkylpyrrolidine ligand. 3hvl 
Tethered PXR-LBD/SRC-1p complexed with SR-12813 3hzf 
Structure of TR-alfa bound to selective thyromimetic GC-1 in C2 space group 3ia6 
X-ray Crystal structure of the nuclear hormone receptor PPAR-gamma in a complex with a PPAR gamma/alpha dual agonist 3ilz 
Structure of TR-alfa bound to selective thyromimetic GC-1 in P212121 space group 3imy 
Structure of TR-beta bound to selective thyromimetic GC-1 3ipq 
X-ray structure of GW3965 synthetic agonist bound to the LXR-alpha 3ips 
X-ray structure of benzisoxazole synthetic agonist bound to the LXR-alpha 3ipu 
X-ray structure of benzisoxazole urea synthetic agonist bound to the LXR-alpha 3ixp 
Crystal structure of the ecdysone receptor bound to BYI08346 3jzb 
Crystal Structure of TR-alfa bound to the selective thyromimetic TRIAC 3jzc 
Crystal Structure of TR-beta bound to the selective thyromimetic TRIAC 3k22 
Glucocorticoid Receptor with Bound alaninamide 10 with TIF2 peptide 3k23 
Glucocorticoid Receptor with Bound D-prolinamide 11 3k6p 
Estrogen Related Receptor alpha in Complex with an Ether Based Ligand 3k8s 
Crystal Structure of PPARg in complex with T2384 3kba 
Progesterone receptor bound to sulfonamide pyrrolidine partial agonist 3kdt 
Crystal structure of peroxisome proliferator-activatedeceptor alpha (PPARalpha) complex with N-3-((2-(4-Chlorophenyl)-5-methyl-1,3-oxazol-4-yl)methoxy)benzyl)-N-(methoxycarbonyl)glycine 3kdu 
Crystal structure of peroxisome proliferator-activatedeceptor alpha (PPARalpha) complex with N-3-((2-(4-Chlorophenyl)-5-methyl-1,3-oxazol-4-yl)methoxy)benzyl)-N-((4-methylphenoxy)carbonyl)glycine 3kfc 
Complex Structure of LXR with an agonist 3kmg 
The X-ray Crystal Structure of PPAR-gamma in Complex with an Indole Derivative Modulator, GSK538, and an SRC-1 Peptide 3kmr 
Crystal structure of RARalpha ligand binding domain in complex with an agonist ligand (Am580) and a coactivator fragment 3kmz 
Crystal structure of RARalpha ligand binding domain in complex with the inverse agonist BMS493 and a corepressor fragment 3kpz 
Crystal structure of a novel vitamin D3 analogue, ZK203278 showing dissociated profile 3kwy 
Crystal structure of RXRalpha ligand binding domain in complex with triphenyltin and a coactivator fragment 3kyt 
Crystal structure of orphan nuclear receptor RORgamma in complex with natural ligand 3l03 
Crystal Structure of human Estrogen Receptor alpha Ligand-Binding Domain in complex with a Glucocorticoid Receptor Interacting Protein 1 Nr Box II peptide and Estetrol (Estra-1,3,5(10)-triene-3,15 alpha,16alpha,17beta-tetrol) 3l0e 
X-ray crystal structure of a Potent Liver X Receptor Modulator 3l0j 
Crystal structure of orphan nuclear receptor RORgamma in complex with natural ligand 3l0l 
Crystal structure of orphan nuclear receptor RORgamma in complex with natural ligand 3l1b 
Complex Structure of FXR Ligand-binding domain with a tetrahydroazepinoindole compound 3l3x 
Crystal structure of DHT-bound androgen receptor in complex with the first motif of steroid receptor coactivator 3 3l3z 
Crystal structure of DHT-bound androgen receptor in complex with the third motif of steroid receptor coactivator 3 3lbd 
LIGAND-BINDING DOMAIN OF THE HUMAN RETINOIC ACID RECEPTOR GAMMA BOUND TO 9-CIS RETINOIC ACID 3lmp 
Crystal structure of the PPARgamma-LBD complexed with a cercosporamide derivative modulator 3m7r 
Crystal structure of VDR H305Q mutant 3mne 
Crystal structure of the agonist form of mouse glucocorticoid receptor stabilized by F608S mutation at 1.96A 3mno 
Crystal structure of the agonist form of mouse glucocorticoid receptor stabilized by (A611V, F608S) mutations at 1.55A 3mnp 
Crystal structure of the agonist form of mouse glucocorticoid receptor stabilized by (A611V, V708A, E711G) mutations at 1.50A 3n00 
Crystal Structure of a deletion mutant of human Reverba ligand binding domain bound with an NCoR ID1 peptide determined to 2.60A 3noa 
Crystal structure of human PPAR-gamma ligand binding domain complex with a potency improved agonist 3nsp 
Crystal structure of tetrameric RXRalpha-LBD 3nsq 
Crystal structure of tetrameric RXRalpha-LBD complexed with antagonist danthron 3o1d 
Structure-function study of Gemini derivatives with two different side chains at C-20, Gemini-0072 and Gemini-0097. 3o1e 
Structure-function of Gemini derivatives with two different side chains at C-20, Gemini-0072 and Gemini-0097. 3oap 
Crystal structure of human Retinoid X Receptor alpha-ligand binding domain complex with 9-cis retinoic acid and the coactivator peptide GRIP-1 3ogt 
Design, Chemical synthesis, Functional characterization and Crystal structure of the sidechain analogue of 1,25-dihydroxyvitamin D3. 3okh 
Crystal structure of human FXR in complex with 2-(4-chlorophenyl)-1-[(1S)-1-cyclohexyl-2-(cyclohexylamino)-2-oxoethyl]-1H-benzimidazole-6-carboxylic acid 3oki 
Crystal structure of human FXR in complex with (2S)-2-[2-(4-chlorophenyl)-1H-benzimidazol-1-yl]-N,2-dicyclohexylethanamide 3olf 
Crystal structure of human FXR in complex with 4-({(2S)-2-[2-(4-chlorophenyl)-5,6-difluoro-1H-benzimidazol-1-yl]-2-cyclohexylacetyl}amino)-3-methylbenzoic acid 3oll 
Crystal structure of phosphorylated estrogen receptor beta ligand binding domain 3ols 
Crystal structure of estrogen receptor beta ligand binding domain 3omk 
Crystal structure of human FXR in complex with (2S)-2-[2-(4-chlorophenyl)-5,6-difluoro-1H-benzimidazol-1-yl]-2-cyclohexyl-N-(2-methylphenyl)ethanamide 3omm 
Crystal structure of human FXR in complex with 4-({(2S)-2-[2-(4-chlorophenyl)-5,6-difluoro-1H-benzimidazol-1-yl]-2-cyclohexylacetyl}amino)-3-fluorobenzoic acid 3omo 
Fragment-Based Design of novel Estrogen Receptor Ligands 3omp 
Fragment-Based Design of novel Estrogen Receptor Ligands 3omq 
Fragment-Based Design of novel Estrogen Receptor Ligands 3oof 
Crystal structure of human FXR in complex with 4-({(2S)-2-[2-(4-chlorophenyl)-5,6-difluoro-1H-benzimidazol-1-yl]-2-cyclohexylacetyl}amino)benzoic acid 3ook 
Crystal structure of human FXR in complex with 4-({(2S)-2-[2-(4-chlorophenyl)-5,6-difluoro-1H-benzimidazol-1-yl]-2-cyclohexylacetyl}amino)-3,5-difluorobenzoic acid 3os8 
Estrogen Receptor 3os9 
Estrogen Receptor 3osa 
Estrogen Receptor 3osi 
Crystal structure of PPARgamma ligand binding domain in complex with tetrachloro-bisphenol A (TCBPA) 3osw 
Crystal structure of PPARgamma ligand binding domain in complex with tetrabromo-bisphenol A (TBBPA) 3oz0 
PPAR Delta in complex with azppard02 3ozj 
Crystal structure of human retinoic X receptor alpha complexed with bigelovin and coactivator SRC-1 3p0u 
Crystal Structure of the ligand binding domain of human testicular receptor 4 3p88 
FXR bound to isoquinolinecarboxylic acid 3p89 
FXR bound to a quinolinecarboxylic acid 3p8x 
Synthesis, Structure, and Biological Activity of des-Side Chain Analogues of 1alpha,25-Dihydroxyvitamin D3 with Substituents at C-18 3pba 
Crystal structure of PPARgamma ligand binding domain in complex with monosulfate tetrabromo-bisphenol A (MonoTBBPA) 3pcu 
Crystal structure of human retinoic X receptor alpha ligand-binding domain complexed with LX0278 and SRC1 peptide 3peq 
PPARd complexed with a phenoxyacetic acid partial agonist 3plz 
Human LRH1 LBD bound to GR470 3po9 
Crystal structure of PPARgamma ligand binding domain in complex with tripropyltin 3prg 
LIGAND BINDING DOMAIN OF HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR 3q95 
Crystal structure of human estrogen receptor alpha LBD in complex with GRIP peptide and estriol 3q97 
Crystal structure of human estrogen receptor alpha LBD in complex with GRIP peptide and two isomers of Ethoxy triphenylethylene 3qt0 
Revealing a steroid receptor ligand as a unique PPARgamma agonist 3r29 
Crystal structure of RXRalpha ligand-binding domain complexed with corepressor SMRT2 3r2a 
Crystal structure of RXRalpha ligand-binding domain complexed with corepressor SMRT2 and antagonist rhein 3r5m 
Crystal structure of RXRalphaLBD complexed with the agonist magnolol 3r5n 
Crystal structure of PPARgammaLBD complexed with the agonist magnolol 3r8a 
X-ray crystal structure of the nuclear hormone receptor PPAR-gamma in a complex with a compound with dual PPAR gamma agonism and Angiotensin II Type I receptor antagonism activity 3r8d 
Activation of the Human Nuclear Xenobiotic Receptor PXR by the Reverse Transcriptase-Targeted Anti-HIV Drug PNU-142721 3r8i 
Crystal Structure of PPARgamma with an achiral ureidofibrate derivative (RT86) 3rlj 
Crystal structure of the androgen receptor ligand binding domain in complex with SARM S-22 3rll 
Crystal structure of the T877A androgen receptor ligand binding domain in complex with (S)-N-(4-Cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanonaphthalen-1-yloxy)-2-hydroxy-2-methylpropanamide 3rut 
FXR with SRC1 and GSK359 3ruu 
FXR with SRC1 and GSK237 3rvf 
FXR with SRC1 and GSK2034 3ry9 
Crystal Structure of the Resurrected Ancestral Glucocorticoid Receptor 1 in complex with DOC 3s9s 
Ligand binding domain of PPARgamma complexed with a benzimidazole partial agonist 3sp6 
Structural basis for iloprost as a dual PPARalpha/delta agonist 3sp9 
Structural basis for iloprost as a dual PPARalpha/delta agonist 3sz1 
Human PPAR gamma ligand binding domain in complex with luteolin and myristic acid 3t03 
Crystal structure of PPAR gamma ligand binding domain in complex with a novel partial agonist GQ-16 3tkc 
Design, Synthesis, Evaluation and Structure of Vitamin D Analogues with Furan Side Chains 3tkm 
Crystal structure PPAR delta binding GW0742 3tx7 
Crystal structure of LRH-1/beta-catenin complex 3ty0 
Structure of PPARgamma ligand binding domain in complex with (R)-5-(3-((3-(6-methoxybenzo[d]isoxazol-3-yl)-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)methyl)phenyl)-5-methyloxazolidine-2,4-dione 3u9q 
Ligand binding domain of PPARgamma complexed with Decanoic Acid and PGC-1a peptide 3up0 
Nuclear receptor DAF-12 from hookworm Ancylostoma ceylanicum in complex with (25S)-delta7-dafachronic acid 3up3 
Nuclear receptor DAF-12 from hookworm Ancylostoma ceylanicum in complex with (25S)-cholestenoic acid 3uu7 
Crystal structure of hERa-LBD (Y537S) in complex with bisphenol-A 3uua 
Crystal structure of hERa-LBD (Y537S) in complex with bisphenol-AF 3uuc 
Crystal structure of hERa-LBD (wt) in complex with bisphenol-C 3uud 
Crystal structure of hERa-LBD (Y537S) in complex with estradiol 3uvv 
Crystal Structure of the ligand binding domains of the thyroid receptor:retinoid X receptor complexed with 3,3',5 triiodo-L-thyronine and 9-cis retinoic acid 3v3e 
Crystal Structure of the Human Nur77 Ligand-binding Domain 3v3q 
Crystal Structure of Human Nur77 Ligand-binding Domain in Complex with Ethyl 2-[2,3,4 trimethoxy-6(1-octanoyl)phenyl]acetate 3v49 
Structure of ar lbd with activator peptide and sarm inhibitor 1 3v4a 
Structure of ar lbd with activator peptide and sarm inhibitor 2 3v9t 
Crystal structure of the PPARgamma-LBD complexed with a cercosporamide derivative modulator 3v9v 
Crystal structure of the PPARgamma-LBD complexed with a cercosporamide derivative modulator 3v9y 
Crystal structure of the PPARgamma-LBD complexed with a cercosporamide derivative modulator 3vhu 
Mineralocorticoid receptor ligand-binding domain with spironolactone 3vhv 
Mineralocorticoid receptor ligand-binding domain with non-steroidal antagonist 3vhw 
Crystal structure of the human vitamin D receptor ligand binding domain complexed with 4-MP 3vi8 
Human PPRR alpha ligand binding domain in complex with a synthetic agonist APHM13 3vjh 
Human PPAR GAMMA ligand binding domain in complex with JKPL35 3vji 
Human PPAR gamma ligand binding domain in complex with JKPL53 3vjs 
Vitamin D receptor complex with a carborane compound 3vjt 
Vitamin D receptor complex with a carborane compound 3vn2 
Crystal Structure of PPARgamma complexed with Telmisartan 3vrt 
VDR ligand binding domain in complex with 2-Mehylidene-19,25,26,27-tetranor-1alpha,24-dihydroxyvitaminD3 3vru 
VDR ligand binding domain in complex with 2-Methylidene-19,24-dinor-1alpha,25-dihydroxy vitaminD3 3vrv 
VDR ligand binding domain in complex with 2-Methylidene-26,27-dimethyl-19,24-dinor-1alpha,25-dihydroxyvitamin D3 3vrw 
VDR ligand binding domain in complex with 22S-Butyl-2-methylidene-26,27-dimethyl-19,24-dinor-1alpha,25-dihydroxyvitamin D3 3vso 
Human PPAR gamma ligand binding domain in complex with a gamma selective agonist mekt21 3vsp 
Human PPAR gamma ligand binding domain in complex with a gamma selective agonist mekt28 3vt3 
Crystal structures of rat VDR-LBD with R270L mutation 3vt4 
Crystal structures of rat VDR-LBD with R270L mutation 3vt5 
Crystal structures of rat VDR-LBD with R270L mutation 3vt6 
Crystal structure of rat VDR-LBD with 2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 3vt7 
Crystal structures of rat VDR-LBD with W282R mutation 3vt8 
Crystal structures of rat VDR-LBD with W282R mutation 3vt9 
Crystal structures of rat VDR-LBD with W282R mutation 3vtb 
Crystal structure of rat vitamin D receptor bound to a partial agonist 25-adamantyl-23-yne-19-norvitammin D ADTK1 3vtc 
Crystal structure of rat vitamin D receptor bound to a partial agonist 26-adamantyl-23-yne-19-norvitammin D ADTK3 3vtd 
Crystal structure of rat vitamin D receptor bound to a partial agonist 26-adamantyl-23-yne-19-norvitammin D ADTK4 3w0a 
Crystal Structure Analysis of Vitamin D receptor 3w0c 
Crystal Structure Analysis of Vitamin D receptor 3w0g 
Crystal Structure of Rat VDR Ligand Binding Domain in Complex with Novel Nonsecosteroidal Ligands 3w0h 
Crystal Structure of Rat VDR Ligand Binding Domain in Complex with Novel Nonsecosteroidal Ligands 3w0i 
Crystal Structure of Rat VDR Ligand Binding Domain in Complex with Novel Nonsecosteroidal Ligands 3w0j 
Crystal Structure of Rat VDR Ligand Binding Domain in Complex with Novel Nonsecosteroidal Ligands 3w0y 
Crystal Structure Analysis of Vitamin D receptor 3w5p 
Crystal structure of complexes of vitamin D receptor ligand binding domain with lithocholic acid derivatives 3w5q 
Crystal structure of complexes of vitamin D receptor ligand binding domain with lithocholic acid derivatives 3w5r 
Crystal structure of complexes of vitamin D receptor ligand binding domain with lithocholic acid derivatives 3w5t 
Crystal structure of complexes of vitamin D receptor ligand binding domain with lithocholic acid derivatives 3wff 
Mineralocorticoid receptor ligand-binding domain with compuond 2b 3wfg 
Mineralocorticoid receptor ligand-binding domain with compuond 2e 3wgp 
3WGP 3wj4 
3WJ4 3wj5 
3WJ5 3wmh 
3WMH 3wt5 
3WT5 3wt6 
3WT6 3wt7 
3WT7 3wtq 
3WTQ 3wwr 
3WWR 3x1h 
3X1H 3x1i 
3X1I 3x31 
3X31 3x36 
3X36 3zqt 
TARGETING THE BINDING FUNCTION 3 SITE OF THE ANDROGEN RECEPTOR THROUGH IN SILICO MOLECULAR MODELING 3zr7 
Structural basis for agonism and antagonism for a set of chemically related progesterone receptor modulators 3zra 
Structural basis for agonism and antagonism for a set of chemically related progesterone receptor modulators 3zrb 
Structural basis for agonism and antagonism for a set of chemically related progesterone receptor modulators 4a2j 
PR X-Ray structures in agonist conformations reveal two different mechanisms for partial agonism in 11beta-substituted steroids 4a4v 
Ligand binding domain of human PPAR gamma in complex with amorfrutin 2 4a4w 
Ligand binding domain of human PPAR gamma in complex with amorfrutin B 4apu 
PR X-Ray structures in agonist conformations reveal two different mechanisms for partial agonism in 11beta-substituted steroids 4b7w 
Ligand binding domain human hepatocyte nuclear factor 4alpha: Apo form 4bcr 
Structure of PPARalpha in complex with WY14643 4ci4 
4CI4 4ci5 
4CI5 4csj 
The discovery of potent selective glucocorticoid receptor modulators, suitable for inhalation 4dk7 
Crystal structure of LXR ligand binding domain in complex with full agonist 1 4dk8 
Crystal structure of LXR ligand binding domain in complex with partial agonist 5 4dm6 
Crystal structure of RARb LBD homodimer in complex with TTNPB 4dm8 
Crystal structure of RARb LBD in complex with 9cis retinoic acid 4dma 
Crystal structure of ERa LBD in complex with RU100132 4dor 
Human Nuclear Receptor Liver Receptor Homologue-1, LRH-1, in its apo State Bound to a Fragment of Human SHP Box1 4dos 
Human Nuclear Receptor Liver Receptor Homologue-1, LRH-1, Bound to DLPC and a Fragment of TIF-2 4dqm 
Revealing a marine natural product as a novel agonist for retinoic acid receptors with a unique binding mode and antitumor activity 4e2j 
X-Ray Crystal Structure of the Ancestral Glucocorticoid Receptor 2 ligand binding domain in complex with mometasone furoate and TIF-2 coactivator fragment 4e4k 
Crystal Structure of PPARgamma with the ligand JO21 4e4q 
Crystal structure of PPARgamma with the ligand FS214 4em9 
Human PPAR gamma in complex with nonanoic acids 4ema 
Human peroxisome proliferator-activated receptor gamma in complex with rosiglitazone 4f9m 
Crystal structure of the PPARgamma-LBD complexed with a cercosporamide derivative modulator 4fgy 
Identification of a unique PPAR ligand with an unexpected binding mode and antibetic activity 4fhh 
Development of synthetically accessible non-secosteroidal hybrid molecules combining vitamin D receptor agonism and histone deacetylase inhibition 4fhi 
Development of synthetically accessible non-secosteroidal hybrid molecules combining vitamin D receptor agonism and histone deacetylase inhibition 4fn9 
X-ray Crystal structure of the Ancestral 3-keto steroid receptor - Progesterone complex 4fne 
X-ray Crystal structure of the Ancestral 3-keto steroid receptor - DOC complex 4g1d 
Structural basis for the accommodation of bis- and tris-aromatic derivatives in Vitamin D Nuclear Receptor 4g1y 
Structural basis for the accommodation of bis- and tris-aromatic derivatives in Vitamin D Nuclear Receptor 4g1z 
Structural basis for the accommodation of bis- and tris-aromatic derivatives in Vitamin D Nuclear Receptor 4g20 
Structural basis for the accommodation of bis- and tris-aromatic derivatives in Vitamin D Nuclear Receptor 4g21 
Structural basis for the accommodation of bis- and tris-aromatic derivatives in Vitamin D Nuclear Receptor 4g2h 
Structural basis for the accommodation of bis- and tris-aromatic derivatives in Vitamin D Nuclear Receptor 4g2i 
Structural basis for the accommodation of bis- and tris-aromatic derivatives in Vitamin D Nuclear Receptor 4hee 
Crystal structure of PPARgamma in complex with compound 13 4hlw 
Targeting the Binding Function 3 (BF3) Site of the Human Androgen Receptor Through Virtual Screening. 2. Development of 2-((2-phenoxyethyl) thio)-1H-benzoimidazole derivatives. 4ia1 
Diastereotopic and Deuterium Effects in Gemini 4ia2 
Diastereotopic and Deuterium Effects in Gemini 4ia3 
Diastereotopic and Deuterium Effects in Gemini 4ia7 
Diastereotopic and Deuterium Effects in Gemini 4iqr 
Multi-Domain Organization of the HNF4alpha Nuclear Receptor Complex on DNA 4is8 
Divergent sequence tunes ligand sensitivity in phospholipid-regulated hormone receptors 4ite 
Crystal structure of the human vitamin D receptor ligand binding domain complexed with 1alpha,25-Dihydroxy-2alpha-[2-(2H-tetrazol-2-yl)ethyl]vitamin D3 4itf 
Crystal structure of the human vitamin D receptor ligand binding domain complexed with 1alpha,25-Dihydroxy-2alpha-[2-(1H-tetrazole-1-yl)ethyl]vitamin D3 4iu7 
Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Constrained WAY-derivative, 2b 4iui 
Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Dynamic WAY derivative, 4a 4iv2 
Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Dynamic WAY-derivative, 5a 4iv4 
Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Constrained WAY-derivative, 5b 4ivw 
Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Constrained WAY-derivative, 6b 4ivy 
Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Dynamic WAY-derivative, 7a 4iw6 
Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Constrained WAY-derivative, 7b 4iw8 
Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Dynamic WAY-derivative, 9a 4iwc 
Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with a Dynamic Thiophene-derivative 4iwf 
Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with a Dynamic Oxime-derivative 4j24 
Estrogen Receptor in complex with proline-flanked LXXLL peptides 4j26 
Estrogen Receptor in complex with proline-flanked LXXLL peptides 4j5w 
Crystal Structure of the apo-PXR/RXRalpha LBD Heterotetramer Complex 4j5x 
Crystal Structure of the SR12813-bound PXR/RXRalpha LBD Heterotetramer Complex 4jaz 
Crystal structure of the complex between PPARgamma LBD and trans-resveratrol 4jgv 
Crystal Structure of Human Nur77 Ligand-binding Domain in Complex with THPN 4jl4 
Crystal structure of the complex between PPARgamma LBD and the ligand LJ570 [(2S)-3-(biphenyl-4-yl)-2-(biphenyl-4-yloxy)propanoic acid] 4jyg 
Crystal structure of RARbeta LBD in complex with agonist BMS411 [4-{[(5,5-dimethyl-8-phenyl-5,6-dihydronaphthalen-2-yl)carbonyl]amino}benzoic acid] 4jyh 
Crystal structure of RARbeta LBD in complex with selective agonist BMS948 [4-{[(8-phenylnaphthalen-2-yl)carbonyl]amino}benzoic acid] 4jyi 
Crystal structure of RARbeta LBD in complex with selective partial agonist BMS641 [3-chloro-4-[(E)-2-(5,5-dimethyl-8-phenyl-5,6-dihydronaphthalen-2-yl)ethenyl]benzoic acid] 4k4j 
Crystal structure of human Retinoid X Receptor alpha-ligand binding domain complex with 9cUAB30 and the coactivator peptide GRIP-1 4k6i 
Crystal structure of human retinoid X receptor alpha-ligand binding domain complex with Targretin and the coactivator peptide GRIP-1 4k7a 
Crystal structure of the androgen receptor ligand binding domain in complex with minoxidil 4kzi 
Crystal Structure of TR3 LBD in complex with DPDO 4kzj 
Crystal Structure of TR3 LBD L449W Mutant 4kzm 
Crystal Structure of TR3 LBD S553A Mutant 4l96 
4L96 4l98 
4L98 4lbd 
LIGAND-BINDING DOMAIN OF THE HUMAN RETINOIC ACID RECEPTOR GAMMA BOUND TO THE SYNTHETIC AGONIST BMS961 4lnw 
Crystal structure of TR-alpha bound to T3 in a second site 4lnx 
Crystal structure of TR-alpha bound to T4 in a second site 4log 
The crystal structure of the orphan nuclear receptor PNR ligand binding domain fused with MBP 4lsj 
Crystal Structure of the Glucocorticoid Receptor Ligand Binding Domain Bound to a Dibenzoxapine Sulfonamide 4ltw 
Ancestral Ketosteroid Receptor-Progesterone-Mifepristone Complex 4m8e 
CRYSTAL STRUCTURE OF HUMAN RETINOID X RECEPTOR ALPHA-LIGAND BINDING DOMAIN COMPLEX WITH (S) 4-Methyl 9cUAB30 COACTIVATOR PEPTIDE GRIP-1 4m8h 
CRYSTAL STRUCTURE OF HUMAN RETINOID X RECEPTOR ALPHA-LIGAND BINDING DOMAIN COMPLEX WITH (R)4-METHYL 9cUAB30 AND COACTIVATOR PEPTIDE GRIP-1 4mdd 
4MDD 4mg5 
4MG5 4mg6 
4MG6 4mg7 
4MG7 4mg8 
4MG8 4mg9 
4MG9 4mga 
4MGA 4mgb 
4MGB 4mgc 
4MGC 4mgd 
4MGD 4n1y 
Crystal Structure of the Pacific Oyster Estrogen Receptor Ligand Binding Domain 4n5g 
Crystal Structure of RXRa LBD complexed with a synthetic modulator K8012 4n73 
4N73 4n8r 
Crystal structure of RXRa LBD complexed with a synthetic modulator K-8008 4nb6 
Crystal structure of the ligand binding domain of RORC with T0901317 4nie 
Crystal structure of the orphan nuclear receptor ROR(gamma)t ligand-binding domain in complex with small molecule ligand 4nqa 
Crystal structure of liganded hRXR-alpha/hLXR-beta heterodimer on DNA 4nuf 
Crystal Structure of SHP/EID1 4ny9 
4NY9 4o8f 
4O8F 4oar 
4OAR 4oc7 
4OC7 4oea 
4OEA 4oed 
4OED 4oey 
4OEY 4oez 
4OEZ 4ofr 
4OFR 4ofu 
4OFU 4ogh 
4OGH 4oh5 
4OH5 4oh6 
4OH6 4oha 
4OHA 4oil 
4OIL 4oiu 
4OIU 4oiv 
4OIV 4oj4 
4OJ4 4oj9 
4OJ9 4ojb 
4OJB 4ok1 
4OK1 4okb 
4OKB 4okt 
4OKT 4okw 
4OKW 4okx 
4OKX 4olm 
4OLM 4oni 
4ONI 4ozr 
4OZR 4ozt 
4OZT 4p6w 
Crystal Structure of mometasone furoate-bound glucocorticoid receptor ligand binding domain 4p6x 
Crystal Structure of cortisol-bound glucocorticoid receptor ligand binding domain 4pf3 
4PF3 4pld 
4PLD 4ple 
4PLE 4poh 
4POH 4poj 
4POJ 4pp3 
4PP3 4pp5 
4PP5 4pp6 
Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Resveratrol 4ppp 
Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Fluoro-Resveratrol 4pps 
Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with an A-CD ring estrogen derivative 4prg 
0072 PARTIAL AGONIST PPAR GAMMA COCRYSTAL 4pvu 
4PVU 4pwl 
4PWL 4pxm 
4PXM 4q0a 
4Q0A 4q13 
4Q13 4q50 
4Q50 4qe6 
4QE6 4qe8 
4QE8 4qjr 
4QJR 4qk4 
4QK4 4ql8 
4QL8 4qm0 
4QM0 4r06 
4R06 4r2u 
4R2U 4r6s 
4R6S 4rak 
4RAK 4re8 
4RE8 4ree 
4REE 4ref 
4REF 4rfw 
4RFW 4rmc 
4RMC 4rmd 
4RMD 4rme 
4RME 4ruj 
4RUJ 4ruo 
4RUO 4rup 
4RUP 4rwv 
4RWV 4rze 
4RZE 4rzf 
4RZF 4rzg 
4RZG 4s0s 
4S0S 4s0t 
4S0T 4s14 
4S14 4s15 
4S15 4tuz 
4TUZ 4tv1 
4TV1 4uda 
4UDA 4udb 
4UDB 4udc 
4UDC 4udd 
4UDD 4umm 
4UMM 4whf 
4WHF 4whg 
4WHG 4wlb 
4WLB 4wpf 
4WPF 4wqp 
4WQP 4wvd 
4WVD 4x1f 
4X1F 4x1g 
4X1G 4xai 
4XAI 4xaj 
4XAJ 4xao 
4XAO 4xhd 
4XHD 4xi3 
4XI3 4xld 
4XLD 4xt9 
4XT9 4xta 
4XTA 4xuh 
4XUH 4xum 
4XUM 4y29 
4Y29 4ymq 
4YMQ 4ynk 
4YNK 4ypq 
4YPQ 4yt1 
4YT1 4zi1 
4ZI1 4zjr 
4ZJR 4zjw 
4ZJW 4zn7 
4ZN7 4zn9 
4ZN9 4znh 
4ZNH 4zns 
4ZNS 4znt 
4ZNT 4znu 
4ZNU 4znv 
4ZNV 4znw 
4ZNW 4zo1 
4ZO1 4zom 
4ZOM 4zsh 
4ZSH 5a86 
5A86 5aau 
5AAU 5aav 
5AAV 5acc 
5ACC 5ak2 
5AK2 5aph 
5APH 5apj 
5APJ 5apk 
5APK 5avi 
5AVI 5avl 
5AVL 5awj 
5AWJ 5awk 
5AWK 5ayg 
5AYG 5azt 
5AZT 5azv 
5AZV 5b5b 
5B5B 5c4o 
5C4O 5c4s 
5C4S 5c4t 
5C4T 5c4u 
5C4U 5cj6 
5CJ6 5di7 
5DI7 5did 
5DID 5die 
5DIE 5dig 
5DIG 5dk9 
5DK9 5dkb 
5DKB 5dke 
5DKE 5dkg 
5DKG 5dks 
5DKS 5dl4 
5DL4 5dlr 
5DLR 5dmc 
5DMC 5dmf 
5DMF 5dp0 
5DP0 5drj 
5DRJ 5drm 
5DRM 5dsh 
5DSH 5dtv 
5DTV 5du5 
5DU5 5due 
5DUE 5dug 
5DUG 5duh 
5DUH 5dv3 
5DV3 5dv6 
5DV6 5dv8 
5DV8 5dvc 
5DVC 5dvs 
5DVS 5dvv 
5DVV 5dwe 
5DWE 5dwg 
5DWG 5dwi 
5DWI 5dwj 
5DWJ 5dwl 
5DWL 5dx3 
5DX3 5dxb 
5DXB 5dxe 
5DXE 5dxg 
5DXG 5dxk 
5DXK 5dxm 
5DXM 5dxp 
5DXP 5dxq 
5DXQ 5dxr 
5DXR 5dy8 
5DY8 5dyb 
5DYB 5dyd 
5DYD 5dz0 
5DZ0 5dz1 
5DZ1 5dz3 
5DZ3 5dzh 
5DZH 5dzi 
5DZI 5e0w 
5E0W 5e0x 
5E0X 5e14 
5E14 5e15 
5E15 5e19 
5E19 5e1c 
5E1C 5e7v 
5E7V 5ec9 
5EC9 5egv 
5EGV 5ehj 
5EHJ 5ei1 
5EI1 5eit 
5EIT 5ejv 
5EJV 5eth 
5ETH 5f9b 
5F9B 5fqp 
5FQP 5fqr 
5FQR 5fqs 
5FQS 5fqt 
5FQT 5fqv 
5FQV 5g42 
5G42 5g43 
5G43 5g44 
5G44 5g45 
5G45 5g46 
5G46 5gt4 
5GT4 5hcv 
5HCV 5hjp 
5HJP 5hjs 
5HJS 5hyk 
5HYK 5hyr 
5HYR 5hzc 
5HZC 5i4v 
5I4V 5ixk 
5IXK 5iz0 
5IZ0 5jy3 
5JY3 5k13 
5K13 5kcc 
5KCC 5kcd 
5KCD 5kce 
5KCE 5kcf 
5KCF 5kct 
5KCT 5kcu 
5KCU 5kcw 
5KCW 5kd9 
5KD9 5kya 
5KYA 5kyj 
5KYJ 5l11 
5L11 5lga 
5LGA 5lwp 
5LWP 5syz 
5SYZ - Links (links to other resources describing this domain)
-
INTERPRO IPR000536 PFAM hormone_rec